Alain Ajamian

Chemical Computing Group ULC provides drug discovery software applications. It offers structure-based design, fragment-based design, Pharmacophore discovery, medicinal chemistry applications, biologics applications, protein and antibody modeling, molecular modeling and simulations, cheminformatics and QSAR and methods development and deployment. The firm's business activities encompass software research and development; worldwide sales, marketing, and support; and collaborative projects. It serves the pharmaceutical, biotechnology, and academic sectors. The company was founded in 1994 and is headquartered in Montreal, Canada.

Chemical Computing Group ULC provides drug discovery software applications. It offers structure-based design, fragment-based design, Pharmacophore discovery, medicinal chemistry applications, biologics applications, protein and antibody modeling, molecular modeling and simulations, cheminformatics and QSAR and methods development and deployment. The firm's business activities encompass software research and development; worldwide sales, marketing, and support; and collaborative projects. It serves the pharmaceutical, biotechnology, and academic sectors. The company was founded in 1994 and is headquartered in Montreal, Canada.

Chemical Computing Group ULC provides drug discovery software applications. It offers structure-based design, fragment-based design, Pharmacophore discovery, medicinal chemistry applications, biologics applications, protein and antibody modeling, molecular modeling and simulations, cheminformatics and QSAR and methods development and deployment. The firm's business activities encompass software research and development; worldwide sales, marketing, and support; and collaborative projects. It serves the pharmaceutical, biotechnology, and academic sectors. The company was founded in 1994 and is headquartered in Montreal, Canada.

Chemical Computing Group ULC provides drug discovery software applications. It offers structure-based design, fragment-based design, Pharmacophore discovery, medicinal chemistry applications, biologics applications, protein and antibody modeling, molecular modeling and simulations, cheminformatics and QSAR and methods development and deployment. The firm's business activities encompass software research and development; worldwide sales, marketing, and support; and collaborative projects. It serves the pharmaceutical, biotechnology, and academic sectors. The company was founded in 1994 and is headquartered in Montreal, Canada.